10-Q: Smart for Life Reports Steep Revenue Decline and Going Concern Warning Amidst Strategic Shifts and Nasdaq Delisting

Smart for Life, Inc. (SMFL) reported a significant decline in revenues and continued net losses for the nine months ended September 30, 2024, raising substantial doubt about its ability to continue as a going concern, following its delisting from Nasdaq.

Summary

• Total revenues for the nine months ended September 30, 2024, decreased by 49.37% to $2,626,080 from $5,186,376 in the prior year period, primarily due to cash constraints impacting raw material purchases for product manufacturing and a near 100% decline in digital marketing advertising revenue.
• The company reported a net loss of $8,343,073 for the nine months ended September 30, 2024, a 35.07% reduction from the $12,848,419 net loss in the same period last year.
• Gross profit for the nine months ended September 30, 2024, decreased by 25.42% to $1,131,801, but the gross profit margin improved to 43.10% from 29.26% in the prior year, attributed to decreased product offerings allowing for a concentration of ingredients.
• Operating expenses significantly decreased by 50.74% to $5,364,534 for the nine months ended September 30, 2024, mainly due to reduced advertising costs, lower insurance rates, and a reduction in headcount.
• Interest expense surged by 35.79% to $4,112,464 for the nine months ended September 30, 2024, compared to $3,028,915 in the prior year period.
• Cash balance as of September 30, 2024, was critically low at $35,608, down from $154,666 at December 31, 2023.
• The company had a working capital deficiency of approximately $8.2 million as of September 30, 2024.
• Smart for Life's common stock was delisted from The Nasdaq Capital Market effective March 31, 2025, and is now quoted on the OTC Pink Market under the symbol SMFL.
• The Ceautamed subsidiary was fully disposed of, with the remaining 49% ownership interest in First Health FL LLC sold for $1.00 on October 1, 2024.
• Bonne Sante Natural Manufacturing, Inc. (BSNM) was reclassified from discontinued to continuing operations, with its operations being relocated from Doral, Florida, to Riviera Beach, Florida, in November 2024.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to severe revenue decline, critical liquidity issues, a 'going concern' warning, Nasdaq delisting, and ineffective internal controls. While net loss decreased and gross margin percentage improved, these are overshadowed by the fundamental challenges to the company's viability.

Positives

• Net loss decreased by 35.07% to $8,343,073 for the nine months ended September 30, 2024, compared to $12,848,419 in the prior year period.
• Loss per share significantly improved to $(3.49) for the nine months ended September 30, 2024, from $(42.13) in the prior year period.
• Gross profit margin percentage increased to 43.10% for the nine months ended September 30, 2024, from 29.26% in the prior year, indicating improved cost efficiency relative to product offerings.
• Operating expenses decreased substantially by 50.74% for the nine months ended September 30, 2024, reflecting successful cost reduction efforts in general and administrative expenses and compensation.
• Net cash used in operating activities significantly reduced to $516,784 for the nine months ended September 30, 2024, from $5,952,710 in the prior year, indicating a much lower operational cash burn.
• Total stockholders' equity shifted from a deficit of $(6,387,454) at December 31, 2023, to a positive equity of $938,457 at September 30, 2024.

Negatives

• Total revenues decreased by 49.37% for the nine months ended September 30, 2024, primarily due to cash constraints limiting raw material purchases and a near 100% decline in digital marketing revenue.
• The company's cash balance is critically low at $35,608 as of September 30, 2024.
• A working capital deficiency of approximately $8.2 million at September 30, 2024, indicates severe short-term liquidity challenges.
• Interest expense increased significantly by 35.79% for the nine months ended September 30, 2024, adding to financial burden.
• The company's common stock was delisted from Nasdaq, moving to the OTC Pink Market, which typically implies reduced liquidity and investor visibility.
• Disclosure controls and procedures were deemed 'not effective' as of September 30, 2024, due to identified material weaknesses in internal control over financial reporting.

Risks

• The company has sustained recurring losses and has a significant deficiency in working capital, raising substantial doubt about its ability to continue as a going concern.
• Management believes currently available resources are not sufficient to fund planned expenditures over the next 12 months, necessitating additional capital raises.
• The inability to secure future financing may have a material adverse effect on the company's financial condition.
• The company was not in compliance with all debt covenants as of September 30, 2024, although waivers were obtained for most, indicating ongoing financial fragility.
• Material weaknesses in internal control over financial reporting persist, leading to ineffective disclosure controls and procedures, which could impact financial reporting reliability.
• The significant decrease in revenues, particularly in the digital marketing business, indicates challenges in core business operations and market demand.
• Reliance on a few major customers (92% of revenues from two customers for nine months ended Sep 30, 2024) and major suppliers (59% of purchases from three suppliers for nine months ended Sep 30, 2024) creates concentration risk.

Future Outlook

The company faces significant challenges in funding its operations, with management stating that currently available resources are insufficient for the next 12 months. It is dependent on raising additional capital through equity or debt financing to implement its business plan. The company is also actively working to remediate material weaknesses in its internal control over financial reporting.

Management Comments

• "Management believes that currently available resources will not be sufficient to fund our planned expenditures over the next 12 months from the date hereof."
• "Accordingly, we will be dependent upon the raising of additional capital through the placement of common and preferred stock as well as debt financing in order to implement our business plan."
• "There is no assurance that we will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on our financial condition."
• "The decreased revenues were the result of a decrease in the volume of products sold and not due to pricing changes."
• "The decrease in revenue [from digital marketing] is attributable to our repurposing of the subsidiary from affiliate network management to focusing on the advertising of our other subsidiaries."
• "The decreased percentage [of cost of revenues to product revenues] is due to decreased product offerings allowing for a concentration of ingredients used in production."
• "Such decrease [in general and administrative expenses] was primarily due to decreased advertising costs and insurance rates in 2024."
• "Such decrease [in compensation expenses] was primarily due to a reduction of headcount."
• "Such percentage increase [in professional services expenses] was primarily due to legal fees and Nasdaq compliance consulting fees incurred."
• "We have identified the steps necessary to address the material weaknesses, and in the third quarter of 2024, we continued to implement these remedial procedures."
• "We have implemented, and plan to continue to implement, new controls and new processes. We have hired and plan to continue to hire additional qualified personnel and establish more robust processes to support our internal control over financial reporting, including clearly defined roles and responsibilities."

Industry Context

Smart for Life operates in the highly competitive nutraceutical and health and wellness industry, alongside a digital marketing segment. The significant revenue decline, particularly in product sales due to cash constraints for raw materials, suggests an inability to compete effectively or meet demand. The repurposing of the digital marketing business indicates a strategic shift away from its previous affiliate network model, possibly in response to underperformance or a re-prioritization of internal advertising needs. The company's 'buy-and-build' strategy appears challenged by its severe liquidity issues, which hinder its ability to acquire new companies or even sustain existing operations. The delisting from Nasdaq further isolates the company from mainstream investment, placing it in a less liquid and less visible market segment.

Comparison to Industry Standards

• The company's substantial revenue decline of nearly 50% for the nine-month period is significantly worse than general industry trends in the nutraceutical and health & wellness sectors, which typically show growth or more modest declines, even in challenging economic environments. For example, larger, more stable players like Herbalife Nutrition Ltd. (HLF) or Nature's Sunshine Products, Inc. (NATR) generally exhibit more stable or growing revenue profiles, albeit with their own market challenges.
• The company's recurring losses and severe working capital deficiency of $8.2 million are far below industry standards, where profitable operations and positive working capital are typical indicators of financial health. Most established nutraceutical companies maintain robust balance sheets to support R&D, marketing, and inventory.
• The company's reliance on a few major customers (92% of revenues from two customers) and suppliers (59% of purchases from three suppliers) is a high concentration risk, atypical for diversified nutraceutical manufacturers or marketers who usually aim for a broader customer and supplier base to mitigate business interruption risks.
• The delisting from Nasdaq to the OTC Pink Market is a severe negative indicator, contrasting sharply with industry peers that maintain listings on major exchanges for better access to capital and investor confidence. This move suggests a failure to meet listing requirements, often related to financial performance or share price.
• The reported 'not effective' internal controls over financial reporting are a significant governance concern, falling short of the robust control environments expected of publicly traded companies, regardless of size, and are a red flag compared to industry best practices for financial transparency and reliability.

Corporate Governance

Legal Proceedings

• The company is not currently aware of any legal proceedings or claims that are reasonably likely to have a material adverse effect on its business, financial condition, or operating results.

Related Party Transactions

• The company has entered into debt agreements with related parties.
• Paid Trilogy Capital Group, LLC, a company controlled by the Executive Chairman, $0 for consulting services for the nine months ended September 30, 2024, compared to $46,686 in the prior year period.

Stakeholder Impact

• **Shareholders**: Significant dilution risk from potential future capital raises, reduced liquidity and visibility due to Nasdaq delisting, and substantial doubt about the company's ability to continue as a going concern, leading to potential loss of investment.
• **Employees**: Reduction in headcount has occurred, indicating job insecurity and potential further workforce adjustments due to financial constraints.
• **Customers**: Cash constraints impacting raw material purchases could lead to disruptions in product availability and manufacturing services, potentially affecting customer relationships and satisfaction.
• **Suppliers**: The company's cash constraints and working capital deficiency may impact its ability to pay suppliers on time, potentially straining relationships and affecting supply chain reliability.
• **Creditors**: The company was not in compliance with all debt covenants as of September 30, 2024, indicating increased risk for lenders, despite waivers obtained for most debt.

Next Steps

• Raise additional capital through common stock, preferred stock, or debt financing to fund operations and implement the business plan.
• Continue implementing remedial procedures to address material weaknesses in internal control over financial reporting.
• Assess and ensure the sustainability of new controls and processes for internal financial reporting.
• Monitor relationships with major customers and suppliers due to high concentration risks.
• Relocate BSNM operations from Doral, Florida, to Riviera Beach, Florida, and surrender the Doral facility to the landlord in November 2024.

Key Dates

Recommendation

Keywords

Nutraceuticals, Health and Wellness, Dietary Supplements, Contract Manufacturing, Weight Management, Digital Marketing, Affiliate Marketing, SEC Filing, 10-Q, Going Concern, Liquidity, Nasdaq Delisting, OTC Markets, Financial Performance, Revenue Decline, Net Loss, Working Capital Deficiency, Debt, Capital Raise, Internal Controls